Orange module banner
Green module banner
Patient Advocacy Organizations
The Alpha-1 Foundation is dedicated to providing the leadership and resources that will result in increased research, improved health, worldwide detection and a cure for alpha-1 antitrypsin deficiency.
Coalition for Hemophilia B
Founded in 1990 by Joyce and John Taylor, a couple whose son was diagnosed with moderate to severe Hemophilia B. The coalition provides patients and their families with information about treatments that will improve quality of life and also works to define new treatment modalities and support efforts to eliminate the disease.
The COPD Foundation was established to improve the lives of individuals affected by COPD. The organization focuses on achieving these results through research, education and advocacy programs that will lead to prevention, and someday, a cure for this disease.
GBS/CIDP Foundation International
The Foundation supports patients and families affected by Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP) or any of the variants.
Hemophilia Federation of America
This community-based organization serves people with bleeding disorders and their families in the U.S. by strengthening community support and awareness, developing effective local organizations and implementing valuable community-based programs.
Immune Deficiency Foundation
IDF provides accurate and timely information to patients diagnosed with a primary immunodeficiency disease in the U.S.
International Patient Organization for Primary Immunodeficiencies
This association of national patient organizations is dedicated to improving awareness, and access to early diagnosis and optimal treatments for primary immunodeficiency patients worldwide.
National Hemophilia Foundation
The NHF is dedicated to finding better treatments and cures for inheritable bleeding disorders and to preventing the complications of these disorders through education, advocacy and research.
Plasma Protein Therapeutics Association
PPTA is a trade association representing a unique sector of the biologics and biotechnology industry.
Safety and Quality in Manufacturing Partners and Organizations
U.S. Food and Drug Administration
The FDA's organization consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations. The FDA licenses and inspects all plasma donation centers.
Clinical Laboratory Improvement Amendments
CLIA regulates laboratory testing and requires clinical labs and and require clinical laboratories to be certificated by their state as well as the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing. All Grifols plasma donor centers must meet CLIA regulations.
COLA is a physician-directed organization that promotes excellence in laboratory medicine and patient care through a program of voluntary education, consultation and accreditation.
European Medicines Agency
The EMA is a decentralized agency responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union. EMA inspects and licenses many Grifols plasma donor centers.
Current Good Manufacturing Practices
Current Good Manufacturing Practices (cGMP) are followed by pharmaceutical and biotech firms to ensure the products they make meet specific requirements for identity, strength, quality and purity.
International Quality Plasma Program
IQPP provides independent, third-party evaluation and recognition of a plasma donation center's adherence to global industry standards for source plasma.
Regierungspräsidium Darmstadt (Regional Council Darmstadt)
RPDA is the German Health Authority that inspects and licenses many Grifols plasma donation centers.